This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Changes in interstitial fluid flow, mass transport and the bone cell response in microgravity and normogravity
Bone Research Open Access 21 November 2022
-
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
BMC Cancer Open Access 03 November 2020
-
Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells
Scientific Reports Open Access 10 March 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goettsch, C. et al. NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. J.Clin. Invest. 123, 4731–4738 (2013)
Rights and permissions
About this article
Cite this article
Harrison, C. Targeting NOX4 knocks down osteoporosis. Nat Rev Drug Discov 12, 904–905 (2013). https://doi.org/10.1038/nrd4182
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4182
This article is cited by
-
Changes in interstitial fluid flow, mass transport and the bone cell response in microgravity and normogravity
Bone Research (2022)
-
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
BMC Cancer (2020)
-
Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells
Scientific Reports (2017)